Director Of New Health Agency Program Determined To Elevate Status Of Minority Biomedical Scientists

Elevate Status Of Minority Biomedical Scientists Author: KAREN YOUNG KREEGER, pp.1 Date: July 11,1994 Researchers, National Institutes of Health administrators, and government officials say the first director of a newly created NIH minority-support program is a fitting choice to lead an office whose creation is long overdue. The new leader is appropriate, they say, because he is both a veteran advocate of minorities in science and

Written byKaren Kreeger
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Elevate Status Of Minority Biomedical Scientists Author: KAREN YOUNG KREEGER, pp.1
Date: July 11,1994

Researchers, National Institutes of Health administrators, and government officials say the first director of a newly created NIH minority-support program is a fitting choice to lead an office whose creation is long overdue. The new leader is appropriate, they say, because he is both a veteran advocate of minorities in science and a minority scientist who has experienced the ups and downs of federal science funding.

Supporters say Clifton A. Poodry is an apt choice to head the Minority Opportunities in Research program because of his relevant personal as well as professional experiences. For example, the 50-year-old member of the Tonawanda Seneca Indian tribe served on the boards of directors of both the American Indian Science and Engineering Society (AISES), based in Boulder, Colo., and the Society for the Advancement of Chicanos and Native Americans in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA